Feedback / Questions
nuvisertib (TP-3654) - Sumitomo Pharma
Nuvisertib: Launch in US/Japan for myelofibrosis in FY 2027
(Sumitomo Dainippon)
-
Jan 31, 2025 -
Q3 FY2024 Results
Launch Japan • Launch US
•
Hematological Malignancies • Myelofibrosis • Oncology
https://www.sumitomo-pharma.com/news/assets/pdf/eir20250131.pdf
Jan 31, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious